The G-Rex® Grant Program is a $20 million initiative by ScaleReady, Wilson Wolf Manufacturing, Bio-Techne, and CellReady, that is designed to propel the advancement of cell and gene therapies (CGT).

G-Rex bioreactors, combined with high-quality reagents, maintain cell phenotype profiles across small and large scale expansion. GMP raw materials for any process at any scale. Raw material quality, supply, and process fit won’t be an issue.

G-Rex® is the only cell culture bioreactor equipped to meet current patient demand for immune cell therapies. Designed for practical cell expansion, G-Rex reproducibly generates a healthy, cell product while enabling parallel patient processing in an footprint.

G-Rex® is the only production platform created specifically to produce immune cells such as T cells, natural killer cells, and hematopoietic cells. G-Rex® is proving to be the most practical and cost effective way to scale up and scale out.

May 29, 2024 · The G-Rex® Grant Program will provide academic and commercial institutions engaged in IND enabling pre-clinical research, process development, and/or ongoing GMP manufacturing of cell and gene therapies with the material resources and services needed to implement or optimize a highly efficient G-Rex® based cell manufacturing platform.

May 29, 2024 · ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced the launch of the G-Rex® Grant Program, a $20 million...

Jan 8, 2025 · ScaleReady's G-Rex Grant Program is a $20M initiative to advance the state of cell and gene-modified cell therapy (CGT) development and manufacturing by awarding individual Grant Awards worth...

ScaleReady delivers scalable immune cell production with GMP cytokines, gene engineering, and G-Rex bioreactors. Learn More.

Nov 7, 2024 · ScaleReady provides the field of cell and gene-modified cell therapy (CGT) with a G-Rex centric manufacturing platform that enables the world's most practical, flexible, scalable, and...

Aug 27, 2024 · ScaleReady's G-Rex Grant Program is a $20M initiative to advance the state of cell and gene-modified cell therapy (CGT) development and manufacturing by awarding individual Grant Awards worth...